ResMed has officially opened its new technology R&D facility in Sandyford in Dublin alongside tánaiste Leo Varadkar.
The San Diego-headquartered digital health company is investing €30 million in R&D, including a plan announced to double its Ireland-based software and technology team with 70 jobs over the next four years to support innovation, technology development, and product development.
This investment is supported by the Irish Government through IDA Ireland.
ResMed provides connected devices, masks, and accessories for the treatment of sleep apnoea, a chronic disease that affects an estimated 936 million people worldwide – including nearly 600,000 in Ireland. Many of ResMed’s digital innovations are developed or enhanced by the company’s Ireland-based “ResMed Sensor Technologies” division.
Speaking at the opening, tánaiste and minister for enterprise, trade and employment Leo Varadkar said: “It was a pleasure to visit ResMed today and officially open the company’s new facility. These 70 new jobs, which ResMed is creating over the next four years, alongside a commitment of €30 million investment in research and development is really welcome. Ireland has become recognised globally for the talent of our workforce, especially in the area of healthcare technology and medical devices. ResMed’s products make a real difference to so many people’s lives and it’s great Ireland is playing such an important role in that effort. The very best of luck to the team.”
Mick Farrell, CEO of ResMed, said: “I’m thrilled to be in Dublin to officially open this state-of-the-art R&D facility. This investment will support the continued growth of ResMed’s product portfolio to meet the needs of patients across Ireland, Europe, and the world. It will also create new capabilities and skills within our expanding team in Ireland and support our global innovation strategy.”
